Arlene F. Kantor
National Institutes of Health
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Arlene F. Kantor.
Epidemiology | 1994
Susan R. Sturgeon; Patricia Hartge; Debra T. Silverman; Arlene F. Kantor; W. Marston Linehan; Charles F. Lynch; Robert N. Hoover
Using data on 1,860 bladder cancer cases and 3,934 population-based controls from the National Bladder Cancer Study, we examined associations between suspected bladder cancer risk factors and tumor stage and grade. Employment in a high-risk occupation was associated with the entire clinical spectrum of bladder cancer rather than a particular tumor stage or grade. For example, relative risks (RR) were similar for noninvasive and invasive disease (1.5 and 1.6, respectively). Cigarette smoking also increased risk of the entire clinical spectrum of bladder cancer, but the more advanced the stage, the stronger the effect. For example, relative risks of noninvasive and invasive bladder cancer for current heavy smokers were 3.0 and 5.2, respectively. Cigarette smoking was associated with higher risk of low-grade than high-grade tumors, once stage of disease was taken into account. Compared with whites, nonwhites were at a lower risk of noninvasive bladder cancer (RR = 0.4) but at similar risk of invasive bladder cancer (RR = 1.1), a pattern indicating racial differences in health practices related to bladder cancer detection. History of urinary tract infections and bladder stones was associated with increasing relative risks for advanced tumor stage. Heavy artificial sweetener use was associated with higher-grade, poorly differentiated tumors. Coffee consumption and family history of bladder cancer were not consistently associated with tumor stage or grade. Overall, different clinical presentations of bladder cancer share most suspected bladder cancer risk factors, including employment in a high-risk occupation and cigarette smoking.
The New England Journal of Medicine | 1989
James A. Talcott; Wendy A. Thurber; Arlene F. Kantor; Edward A. Gaensler; Jane Danahy; Karen H. Antman; Frederick P. Li
To estimate the effects on health of occupational exposure to crocidolite, a highly toxic form of asbestos, we studied a cohort of 33 men who worked in 1953 in a Massachusetts factory that manufactured cigarette filters containing crocidolite fibers from 1951 to 1957. Twenty-eight of the men have died, as compared with 8.3 deaths expected. This increased mortality was attributable to asbestos-associated diseases. Fifteen deaths were caused by cancer, as compared with 1.8 expected (relative risk, 8.2; 95 percent confidence interval, 4.6 to 13.4), including eight from lung cancer, five from malignant mesothelioma, and two from other types of cancer. There were seven deaths from nonmalignant respiratory disease, as compared with 0.5 expected (relative risk, 14.7; 95 percent confidence interval, 5.9 to 30.3), of which five were due primarily to asbestosis. In contrast, the mortality rates from cardiovascular diseases and all other causes were not increased. Four of the five living workers have pulmonary asbestosis; three of them have recently diagnosed cancers, including two additional lung cancers. We conclude that the extremely high morbidity and mortality in these workers were caused by intense exposure to crocidolite asbestos fibers.
Cancer | 1985
Patricia Hartge; Robert N. Hoover; Arlene F. Kantor
Interview data from 2982 patients with bladder cancer and 5782 controls selected from the general population were used to assess the effects of non‐cigarette tobacco use on bladder cancer risk. Compared to men who had never smoked, those who had smoked pipes but not cigars or cigarettes had a relative risk estimated at 1.23 (95% confidence interval [CI] = 0.75–2.00). Those who smoked cigars but not pipes or cigarettes were estimated to have a relative risk of 1.33 (95% CI = 0.92–1.94). Little evidence of dose response was observed. The excess relative risk to pipe smokers was limited to those who inhaled deeply.
Cancer Research | 1991
Judy Garber; Alisa M. Goldstein; Arlene F. Kantor; Margaret G. Dreyfus; Joseph F. Fraumeni; Frederick P. Li
American Journal of Epidemiology | 1984
Arlene F. Kantor; Patricia Hartge; Robert N. Hoover; Ambati S. Narayana; Jerry W. Sullivan; Joseph F. Fraumeni
Cancer Research | 1988
Arlene F. Kantor; Patricia Hartge; Robert N. Hoover; Joseph F. Fraumeni
American Journal of Epidemiology | 1987
Arlene F. Kantor; Robert N. Hoover; L.J. Kinlen; Michael R. McMULLAN; Joseph F. Fraumeni
International Journal of Cancer | 1985
Arlene F. Kantor; Patricia Hartge; Robert N. Hoover; Joseph F. Fraumeni
Journal of the National Cancer Institute | 1976
Arlene F. Kantor; J. Wister Meigs; Jean F. Heston; John T. Flannery
Journal of Clinical Oncology | 1989
Arlene F. Kantor; Frederick P. Li; Abbe J. Janov; Nancy J. Tarbell; Stephen E. Sallan